Director, Biosimilars Launch

Description

• Partners with the Senior Director (Biosimilars Launch Pillar) to lead the development of integrated US launch strategies across multiple biosimilar pipeline assets, setting the strategic direction and ensuring alignment with Teva’s long‑range plan
• Serves as the commercialization lead driving cross‑functional governance, decision‑making, and alignment with cross-functional partners
• Shapes and enhances the U.S. biosimilar launch operating model, ensuring repeatability, process optimization, and best practice sharing across assets
• Leads development and execution of US Biosimilars launch readiness frameworks, KPIs, and operating mechanisms
• Co-leads launch meeting planning with other internal partners
• Collaborates with market access teams on payer strategy and pull through
• Collaborates with trade teams on distribution and specialty pharmacy strategy
• Works with both internal and external partners to create, develop and drive strategy and direction of the future biosimilar launch assets
• Assists in go-to-market strategy development, long range planning and annual operating process (budget setting)
• Supports market research to enable future launches in collaboration with insights team, analyzes market data and information and makes informed decisions
• Aligns organizationally and individually with internal and external codes of conduct
• Collaborates and aligns with Teva’s global biosimilars team

Qualifications

• Bachelor’s degree required; Master’s degree preferred
• Minimum 10 years of pharmaceutical experience
• Minimum 7 years of pharmaceutical marketing experience or equivalent

Preferred Experience

• Launch experience in multiple therapeutic spaces; oncology, auto immune, etc
• Strong understanding of market access with a proficiency in both pharmacy and medical benefit are required to succeed in the role
• Biosimilars background would be a plus